eTect Announces Initiation of a Clinical Study Using Its Novel Ingestion Event Monitoring System to Reliably Track Opioid Use for Pain Management

This study has been designed to evaluate use of the ID-Cap System in monitoring and improving medication adherence. Additional clinical validation studies in partnership with pharmaceutical companies, the NIH, and academic research organizations are planned for 2016. eTect’s technology enables an objective measurement of medication ingestion with real-time reporting of time-stamped dose ingestion events, ensuring that this important information is available to doctors who need it to provide the best care to their patients. The ID-Cap System allows a definitive understanding of medication-taking behavior that has the potential to transform how medications are evaluated by clinical researchers, prescribed by doctors, and used by patients. Medication Adherence Nonadherence to prescribed medications is an important consideration in the clinical management of patients and in clinical research and drug development. Considerable research has been conducted to elucidate the reasons for nonadherence, which are often unique to the individual patient and the specific medication of interest. Across different disease states and medications, nonadherence directly impacts drug exposure and therapeutic outcomes. An estimated 50% of patients in developed countries are not adherent to prescribed medications for chronic health conditions, and the magnitude and impact of the problem are even greater in developing countries. Poor adherence is associated with increased healthcare costs and contr...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: News Event Monitoring System ingestible tracking device opioids patient adherence patient compliance Source Type: research